Medications and Hyponatremia Risk
Among the medications listed, diuretics (if metoprolol extended-release is combined with a diuretic), sitagliptin, and alprazolam carry documented risk for hyponatremia, while metoprolol, atorvastatin, aspirin, metformin, and voglibose are not established causes of hyponatremia.
Individual Medication Analysis
High-Risk Medications
Sitagliptin (DPP-4 Inhibitor)
- While the 2019 Endocrine Society guideline notes that DPP-4 inhibitors are "generally well tolerated" 1, multiple pharmacovigilance studies identify sitagliptin as a cause of hyponatremia 2, 3, 4
- The 2022 European Heart Journal guideline specifically warns to "avoid sitagliptin in patients with HF" 5, though this relates to heart failure risk rather than hyponatremia
- Clinical action: Monitor sodium levels, particularly in elderly patients or those on other medications that affect sodium balance
Alprazolam (Benzodiazepine)
- Benzodiazepines are recognized causes of drug-induced hyponatremia 6, 7
- Risk increases with advanced age, female gender, and polypharmacy 6
- Hyponatremia typically develops within the first 2 weeks of treatment 6
- Clinical action: Check sodium levels within 1-2 weeks of initiation, especially in patients >65 years
Medications NOT Associated with Hyponatremia
Metoprolol Extended-Release (Beta-Blocker)
- Beta-blockers are not listed as causes of hyponatremia in comprehensive reviews 8, 2, 3
- The 2025 AHA/ACC hypertension guidelines do not identify beta-blockers as causing electrolyte disturbances 9, 10
- However: If combined with diuretics (common in heart failure or hypertension), monitor for diuretic-induced hyponatremia
Atorvastatin (Statin)
- No evidence links statins to hyponatremia in guideline or research literature 5, 8, 2
- Not mentioned in comprehensive drug-induced hyponatremia reviews
Aspirin (Ecospirin)
- NSAIDs can cause sodium retention (not depletion) 11, 12
- Aspirin specifically is not associated with hyponatremia 8, 2, 3
Metformin
- The FDA label for metformin does not list hyponatremia as an adverse effect 13
- Primary concerns are lactic acidosis and vitamin B12 deficiency 1, 13
- Not identified in drug-induced hyponatremia surveillance studies 4
Voglibose (Alpha-Glucosidase Inhibitor)
- The 2019 Endocrine Society guideline notes alpha-glucosidase inhibitors have "gastrointestinal adverse effects of flatulence and diarrhea" but not electrolyte disturbances 1
- Not mentioned in comprehensive hyponatremia reviews 8, 2, 3, 4
Critical Monitoring Considerations
High-Risk Patient Profile for Drug-Induced Hyponatremia
- Age >65 years (71.9% of cases) 7
- Female gender (63.7% of cases) 7
- Polypharmacy (multiple medications affecting sodium/water balance)
- Concurrent diuretic use 9, 10
Timing of Onset
- Early risk: 70% of hyponatremia cases occur within first year of treatment 7
- Peak risk: First 2 weeks for psychotropic medications 6
- Late risk: Can occur after years (median 79 days, range 1-7030 days) 7
When to Check Sodium Levels
According to 2025 AHA/ACC guidelines, check basic metabolic panel 2-4 weeks after initiation or dose changes of medications affecting electrolytes 9, 10. For your patient's regimen:
- Check sodium: When starting or adjusting sitagliptin or alprazolam
- Routine monitoring: Not required for metoprolol, atorvastatin, aspirin, metformin, or voglibose based solely on hyponatremia risk
Common Pitfall
The 2025 AHA/ACC guidelines specifically note that "hyponatremia may be caused by diuretics, in particular thiazide-type diuretics" 9, 10. If your patient develops hyponatremia while on this regimen, first investigate whether they are also taking diuretics (loop or thiazide), as these are the most common culprits with the highest reporting rates 14, 7. Hydrochlorothiazide had the highest case count in Spanish pharmacovigilance data 7.